Skip to main content

Latest News

New study reveals breast cancer drug combination has impact on other cancers

4 Mar 2024
Photo: Professor Roisin Connolly, Director of Cancer Research at University College Cork.
  • Drug commonly used to treat HER2-positive breast cancer sees tumour shrinkage in several other cancer types.
  • Cancer treatment combination may have more uses than previously thought.

UCC Research

Aistriú Taighde

Office of Vice President for Research & Innovation, 4th Floor, Block E, Food Science Building University College Cork, T12 K8AF

Top